Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...

Insulin use in gestational diabetes presents challenges; education and support are key to overcoming fears and ensuring ...

Analysis of the medical records of 1,269 elderly patients with advanced cancer by researchers at the University of Tsukuba ...

By combining genomic and plasma proteomic data from a Ugandan cohort, the researchers mapped nearly 400 genetic regions that ...

Check out some of the medications affected by drugmakers raising prices on life-saving medications this year, as well as some ...

When Medicare Coverage Falls Short Picture this: you're 67, finally retired with your Medicare card safely tucked in your ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a ...

Diabetes mellitus could drain tens of trillions from the global economy, with informal caregiving emerging as the largest hidden cost.

Speaking at the J.P. Morgan conference, CEO David Ricks said he anticipates a “rapid review” for orforglipron that's ...

Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...

Artificial intelligence is already helping women to sleep better, spot warning signs of conditions early on, and has the ...